Expert Ratings for Cellebrite DI
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Cellebrite DI (NASDAQ:CLBT) stock, with 3 being bullish, 1 somewhat bullish, and none bearish. The average 12-month price target for the stock is $9.5, with a high of $11.00 and a low of $7.00. This average price target has increased by 26.67% over the past month.
August 09, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts are generally bullish on Cellebrite DI (NASDAQ:CLBT), with an average 12-month price target of $9.5. This target has increased by 26.67% over the past month.
The bullish sentiment from analysts and the increase in the average price target over the past month suggest a positive short-term impact on Cellebrite DI's stock. The price target indicates where analysts collectively believe the stock will move, which can influence investor sentiment and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100